JPRN-UMIN000025834
Recruiting
未知
Study of predictive factors of adverse events and therapeutic effects of immune checkpoint inhibitors in patients with solid cancer. - To Investigate Marker of adverse events and therapeutic effects of immune-checkpoint inhibitors
Department of Internal Medicine, Division of Medical Oncology, Showa University School of Medicine0 sites20 target enrollmentJanuary 24, 2017
Conditionssolid cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- solid cancer
- Sponsor
- Department of Internal Medicine, Division of Medical Oncology, Showa University School of Medicine
- Enrollment
- 20
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\) HBs antigen, HCV antibody, HIV antibody are positive. (2\) An inappropriate case judged by doctor in charge.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Association between adverse events and prognosis in postoperative adjuvant chemotherapy for colorectal cancerColorectal cancerJPRN-UMIN000047961Japanese Foundation for Multidisciplinary Treatment of Cancer4,212
Recruiting
Not Applicable
Validating predictive factors of complications and effectiveness of ERCP/EUS through prospective registry in patients with pancreatobiliary disordersDiseases of the digestive systemKCT0002082Gachon University Gil Medical Center5,000
Completed
Not Applicable
Analysis of risk factors and prognostic factors included histological status of underlying liver disease of patients undergoing curative resection or radiofrequency ablation of hepatocellular carcinoma; May hepatic steatosis correlate with the postoperative recurrence of hepatocellular carcinoma?Patients with Hepatocellular carcinoma(HCC) after curative treatmentJPRN-UMIN000000970Department of Internal Medicine, National Hospital Organization IwakuniClinical Center400
Not yet recruiting
Not Applicable
A study on the short and long term outcomes of patients diagnosed with a fungal disease called Mucormycosis (commonly known as Black Fungus)CTRI/2021/09/036254Dr Manickam P
Recruiting
Phase 3
Determining factors of prognosis and morbidity in Chronic Chagas Heart Disease - phase IIIRBR-9gm9bzniversidade Federal de Minas Gerais